San Francisco-based Woodline Partners LP is a private equity firm specializing in global Health Care and Technology sectors.
83
Operating
2018
Woodline Partners is a San Francisco-based investment firm specializing in global Health Care and Technology sectors. The firm implements a fundamental sub-sector equity strategy, focusing on North American, European, and Asian markets. Woodline's approach emphasizes bottom-up analysis and leverages an established network of corporate executive and industry relationships.
The firm's portfolio includes notable companies such as Amylyx Pharmaceuticals, ElevateBio, Odyssey Therapeutics, and Patreon. Woodline Partners typically invests in Series B and later stages, including post-IPO equity rounds. Their investment strategy aims to hedge unpredictable factors and focus on company-specific details to assess long-term potential.
Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Portfolio Companies29
Follow-on Investments3
Current Portfolio Count26
Total Portfolio Exits3
Top Investment Stages
Series B10 (50.0%)
Series C4 (20.0%)
Series A2 (10.0%)
Series D2 (10.0%)
Series F2 (10.0%)
Stage Mix
Series B 50%Series C 20%Series A 10%Series D 10%Series F 10%
Concentration shown as share of disclosed investments by stage.
